Home LiteratureArticle Details
PMID: 1767253 Published · ppublish English Comparative Study Journal Article Research Support, Non-U.S. Gov't

Bacteriuria in patients treated with clean intermittent catheterization.

Scandinavian journal of infectious diseases ·Vol. 23 ·No. 5 ·1991-00-00 ·Pages 577-82

Bakke A, Digranes A

Abstract

Bacteriuria has been studied in 407 patients treated with clean intermittent catheterization (CIC) during 1 year. Significant bacteriuria was found in 50.6% of 1413 analyzed urine samples. Escherichia coli was the dominating species (54.8%). The relative distribution of species was different in males and females, but there were no differences between the CIC patients and a reference group of outpatients. On the other hand, a higher frequency of resistance among enterobacteria was found in samples from CIC patients compared to the reference group. The majority of CIC patients with bacteriuria had no symptoms, and bacteriuria per se does not seem to be an indication for treatment in most of these patients.

MeSH Terms
Adolescent Adult Aged Aged, 80 and over Bacteriuria/microbiology,therapy Drug Resistance, Microbial Enterobacteriaceae/isolation & purification Enterobacteriaceae Infections/microbiology Escherichia coli/isolation & purification Escherichia coli Infections/microbiology,therapy Female Humans Male Middle Aged Sex Factors Time Factors Urinary Catheterization Urinary Retention/therapy
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Bakke A
Department of Surgery, University of Bergen, Haukeland Hospital, Norway.
Digranes A
Article Info
Journal
Scandinavian journal of infectious diseases
Abbr.
Scand J Infect Dis
ISSN
0036-5548
Published
1991-00-00
Pages
577-82
Language
English
Region
England
NLM ID
0215333
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com